Sonnet BioTherapeutics Holdings, Inc. 4 SEC Filings

Filed On	Filing
04 Dec 2025	Form 4: Kenney Richard T, Chief Medical Officer Returned 242,748 shares to the issuer · Received 250,265 shares by exercise or conversion · Gave up 16,891 shares to cover exercise price or tax · 1 more
03 Dec 2025	Form 4: Mcandrew Stephen J, Chief Business Officer Returned 6,446 shares to the issuer
03 Dec 2025	Form 4: Griffith Donald J., Director Returned 10,375 shares to the issuer
03 Dec 2025	Form 4: McNeill Lori, Director Returned 4,394 shares to the issuer
03 Dec 2025	Form 4: Dexter Susan, Director Returned 9,643 shares to the issuer
03 Dec 2025	Form 4: Rao Raghu, Director Returned 22,356 shares to the issuer
03 Dec 2025	Form 4: Cini John K., Director Returned 14,116 shares to the issuer
03 Dec 2025	Form 4: Bhatt Nailesh, Director Returned 10,547 shares to the issuer
03 Dec 2025	Form 4: Dyrness Albert D., Director Returned 4,537 shares to the issuer
21 Aug 2025	Form 4: Kenney Richard T, Chief Medical Officer Granted 86,505 Warrant · Granted 320,000 Warrant · Granted 200 Series 5 Preferred Stock
15 Jul 2025	Form 4: Dyrness Albert D., Director Received 4,000 shares as a grant or award
15 Jul 2025	Form 4: Rao Raghu, Director Received 20,000 shares as a grant or award
15 Jul 2025	Form 4: Mcandrew Stephen J, Chief Business Officer Received 6,000 shares as a grant or award
15 Jul 2025	Form 4: McNeill Lori, Director Received 4,000 shares as a grant or award
15 Jul 2025	Form 4: Griffith Donald J., Director Received 10,000 shares as a grant or award
15 Jul 2025	Form 4: Kenney Richard T, Chief Medical Officer Received 8,000 shares as a grant or award
15 Jul 2025	Form 4: Bhatt Nailesh, Director Received 10,000 shares as a grant or award
15 Jul 2025	Form 4: Dexter Susan, Chief Technical Officer Received 8,000 shares as a grant or award
15 Jul 2025	Form 4: Cini John K., Chief Scientific Officer Received 12,000 shares as a grant or award
05 Dec 2024	Form 4: Bhatt Nailesh, Director Received 373 shares as a grant or award

Comments